Global Medical REIT Inc.
GMRE · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.54 | -0.26 | 0.16 | -0.38 |
| FCF Yield | 0.00% | -19.76% | -19.07% | -32.31% |
| EV / EBITDA | -14.71 | 63.54 | 32.22 | 30.89 |
| Quality | ||||
| ROIC | -10.68% | 0.43% | 0.78% | 0.53% |
| Gross Margin | -151.77% | 78.31% | 78.07% | 79.41% |
| Cash Conversion Ratio | -3.47 | 37.84 | 3.45 | 6.98 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.83% | -0.63% | -0.88% | 0.27% |
| Free Cash Flow Growth | 0.00% | 17.93% | 33.07% | -255.04% |
| Safety | ||||
| Net Debt / EBITDA | 0.24 | 59.66 | 27.53 | 26.66 |
| Interest Coverage | 0.00 | 1.04 | 1.33 | 0.85 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 19.15 | -188.51 | -150.10 | -186.18 |